3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Leukemia, Myeloid, Acute
13
Myelodysplastic Syndromes
11
Hodgkin Disease
8
Lymphoma, Non-Hodgkin
7
Multiple Myeloma
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Leukemia, Myelomonocytic, Chronic
5
Myeloproliferative Disorders
4
Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia
4
Burkitt Lymphoma
4
Anemia, Refractory, with Excess of Blasts
4
Recurrence
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Leukemia, Myeloid, Accelerated Phase
3
Leukemia, Biphenotypic, Acute
3
Colorectal Neoplasms
3
Blastic Plasmacytoid Dendritic Cell Neoplasm
3
Stomach Neoplasms
2
Sarcoma
2
Primary Myelofibrosis
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Neuroblastoma
2
Neoplasms, Plasma Cell
2
Interventions
dolutegravir
1
Tenofovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia-Lymphoma, Adult T-Cell
×
fludarabine phosphate
×
30 days
×
Clear all
No trials found.